The Effect of Aromatherapy Applied After Cesarean Section on Pain Intensity and Comfort Level

Sponsor
KTO Karatay University (Other)
Overall Status
Recruiting
CT.gov ID
NCT06008964
Collaborator
Şerife İrem DÖNER (Other), Merve YAZAR (Other), JULE ERİÇ HORASANLI (Other)
96
1
3
2.5
38.4

Study Details

Study Description

Brief Summary

Today, many complementary therapies such as acupuncture, reflexology, homeopathy, hypnotherapy, music and aromatherapy are tried in addition to medical methods to reduce pain and anxiety. Aromatherapy is a therapy method in which essential oils are used to protect and improve physical and psychological health. Oils can be applied directly to a single person or indirectly to people in a room by inhalation . In direct application without steam, essential oils can be applied by inhalation by dripping onto a cotton ball . It is stated that lavender aromatherapy, one of the most commonly used aromatherapies, has analgesic, antiseptic, sedative, antispasmodic and healing properties Ylang Ylang aromatherapy is stated analgesic, anti-inflammatory, antimicrobial, antiemetic,anti-tarral, carminative, sedative, antiseptic, spasmolytic properties. In the studies conducted, anxiety, labor pain, labor duration, and psychological effects of aromatherapy were examined, but no study was found in which lavender and chamomile essential oils were used and the effects of pain and comfort level were examined. The aim of this study is to determine the effect of lavender and Ylang Ylang essential oils in relieving pain and increasing comfort after cesarean section.

Condition or Disease Intervention/Treatment Phase
  • Other: Ylang Ylang oil with inhalation
  • Other: Lavender oil with inhalation
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
96 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Triple (Care Provider, Investigator, Outcomes Assessor)
Primary Purpose:
Supportive Care
Official Title:
Determination of the Effect of Aromatherapy Using Lavender and Ylang Ylang Essential Oils on Pain Severity and Comfort Level After Cesarean Section: A Randomized Controlled Study
Actual Study Start Date :
Jun 15, 2023
Actual Primary Completion Date :
Aug 17, 2023
Anticipated Study Completion Date :
Aug 30, 2023

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Ylang Ylang oil Group

GROUP 1

Other: Ylang Ylang oil with inhalation
Ylang Ylang OIL WILL BE INHALED

No Intervention: Control Group

No intervention

Active Comparator: Lavender oil

GROUP 2

Other: Lavender oil with inhalation
LAVENDER OIL WILL BE INHALED

Outcome Measures

Primary Outcome Measures

  1. pain related to cesarean section [post operative 4-8-12 hours]

    It will be measured with Visual Analog Scale. Visual Analog Scale has a rating between 0-10. The higher the score, the greater the pain.

Secondary Outcome Measures

  1. comfort related to cesarean section [post operative 4-8-12 hours]

    Comfort will be measured with the postpartum comfort scale. The higher the score, the higher the comfort level.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 49 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • 18-49 years old,

  • women who have had a cesarean section

Exclusion Criteria:
  • epilepsy,

  • migraine,

  • chronic headache,

  • asthma,

  • women who are allergic to fragrance sensitivities to aromatic oils

Contacts and Locations

Locations

Site City State Country Postal Code
1 KTO Karatay University Konya Turkey 42000

Sponsors and Collaborators

  • KTO Karatay University
  • Şerife İrem DÖNER
  • Merve YAZAR
  • JULE ERİÇ HORASANLI

Investigators

  • Study Chair: şerife irem döner, serifeiremdoner@gmail.com
  • Study Chair: Merve Yazar, merve.yazar@karatay.edu.tr

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Hafize Dağ Tüzmen, LECTURER, KTO Karatay University
ClinicalTrials.gov Identifier:
NCT06008964
Other Study ID Numbers:
  • Aromatherapy Group
First Posted:
Aug 24, 2023
Last Update Posted:
Aug 24, 2023
Last Verified:
Aug 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Hafize Dağ Tüzmen, LECTURER, KTO Karatay University

Study Results

No Results Posted as of Aug 24, 2023